ProfileGDS4459 / ENSG00000172943
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 55% 64% 77% 52% 68% 67% 74% 78% 72% 80% 59% 75% 75% 24% 73% 39% 58% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.5955
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.964
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.9577
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.5752
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.2168
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.0967
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.7374
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.0278
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.5872
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.1180
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.6659
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.875
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.775
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.5824
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.6773
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.0739
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.6758